194 related articles for article (PubMed ID: 12535798)
1. In situ binding assay for studying chemokine interactions with endothelial cells.
Rot A
J Immunol Methods; 2003 Feb; 273(1-2):63-71. PubMed ID: 12535798
[TBL] [Abstract][Full Text] [Related]
2. A high endothelial venule-expressing promiscuous chemokine receptor DARC can bind inflammatory, but not lymphoid, chemokines and is dispensable for lymphocyte homing under physiological conditions.
Kashiwazaki M; Tanaka T; Kanda H; Ebisuno Y; Izawa D; Fukuma N; Akimitsu N; Sekimizu K; Monden M; Miyasaka M
Int Immunol; 2003 Oct; 15(10):1219-27. PubMed ID: 13679391
[TBL] [Abstract][Full Text] [Related]
3. [Molecular basis and structure-activity relationships of the Duffy blood group antigens: chemokine and Plasmodium vivax receptors].
Tournamille C
Transfus Clin Biol; 2000 Oct; 7(5):497-509. PubMed ID: 11109635
[TBL] [Abstract][Full Text] [Related]
4. Sequence, evolution and ligand binding properties of mammalian Duffy antigen/receptor for chemokines.
Tournamille C; Blancher A; Le Van Kim C; Gane P; Apoil PA; Nakamoto W; Cartron JP; Colin Y
Immunogenetics; 2004 Jan; 55(10):682-94. PubMed ID: 14712331
[TBL] [Abstract][Full Text] [Related]
5. Expression of the duffy antigen/receptor for chemokines (DARC) by the inflamed synovial endothelium.
Patterson AM; Siddall H; Chamberlain G; Gardner L; Middleton J
J Pathol; 2002 May; 197(1):108-16. PubMed ID: 12081195
[TBL] [Abstract][Full Text] [Related]
6. The Duffy antigen/receptor for chemokines (DARC) is expressed in endothelial cells of Duffy negative individuals who lack the erythrocyte receptor.
Peiper SC; Wang ZX; Neote K; Martin AW; Showell HJ; Conklyn MJ; Ogborne K; Hadley TJ; Lu ZH; Hesselgesser J; Horuk R
J Exp Med; 1995 Apr; 181(4):1311-7. PubMed ID: 7699323
[TBL] [Abstract][Full Text] [Related]
7. Chemokine class differences in binding to the Duffy antigen-erythrocyte chemokine receptor.
Szabo MC; Soo KS; Zlotnik A; Schall TJ
J Biol Chem; 1995 Oct; 270(43):25348-51. PubMed ID: 7592697
[TBL] [Abstract][Full Text] [Related]
8. Expression of chemokines and chemokine receptors during human renal transplant rejection.
Segerer S; Cui Y; Eitner F; Goodpaster T; Hudkins KL; Mack M; Cartron JP; Colin Y; Schlondorff D; Alpers CE
Am J Kidney Dis; 2001 Mar; 37(3):518-31. PubMed ID: 11228176
[TBL] [Abstract][Full Text] [Related]
9. Binding of RANTES, MCP-1, MCP-3, and MIP-1alpha to cells in human skin.
Hub E; Rot A
Am J Pathol; 1998 Mar; 152(3):749-57. PubMed ID: 9502417
[TBL] [Abstract][Full Text] [Related]
10. The Duffy antigen receptor for chemokines: structural analysis and expression in the brain.
Horuk R; Martin A; Hesselgesser J; Hadley T; Lu ZH; Wang ZX; Peiper SC
J Leukoc Biol; 1996 Jan; 59(1):29-38. PubMed ID: 8558064
[TBL] [Abstract][Full Text] [Related]
11. The Duffy antigen receptor for chemokines is up-regulated during acute renal transplant rejection and crescentic glomerulonephritis.
Segerer S; Regele H; MacK M; Kain R; Cartron JP; Colin Y; Kerjaschki D; Schlöndorff D
Kidney Int; 2000 Oct; 58(4):1546-56. PubMed ID: 11012889
[TBL] [Abstract][Full Text] [Related]
12. A role of the Duffy antigen for the maintenance of plasma chemokine concentrations.
Fukuma N; Akimitsu N; Hamamoto H; Kusuhara H; Sugiyama Y; Sekimizu K
Biochem Biophys Res Commun; 2003 Mar; 303(1):137-9. PubMed ID: 12646177
[TBL] [Abstract][Full Text] [Related]
13. Silent chemoattractant receptors: D6 as a decoy and scavenger receptor for inflammatory CC chemokines.
Locati M; Torre YM; Galliera E; Bonecchi R; Bodduluri H; Vago G; Vecchi A; Mantovani A
Cytokine Growth Factor Rev; 2005 Dec; 16(6):679-86. PubMed ID: 15996892
[TBL] [Abstract][Full Text] [Related]
14. Duffy antigen facilitates movement of chemokine across the endothelium in vitro and promotes neutrophil transmigration in vitro and in vivo.
Lee JS; Frevert CW; Wurfel MM; Peiper SC; Wong VA; Ballman KK; Ruzinski JT; Rhim JS; Martin TR; Goodman RB
J Immunol; 2003 May; 170(10):5244-51. PubMed ID: 12734373
[TBL] [Abstract][Full Text] [Related]
15. The beta-chemokine receptor D6 is expressed by lymphatic endothelium and a subset of vascular tumors.
Nibbs RJ; Kriehuber E; Ponath PD; Parent D; Qin S; Campbell JD; Henderson A; Kerjaschki D; Maurer D; Graham GJ; Rot A
Am J Pathol; 2001 Mar; 158(3):867-77. PubMed ID: 11238036
[TBL] [Abstract][Full Text] [Related]
16. The promiscuous chemokine binding profile of the Duffy antigen/receptor for chemokines is primarily localized to sequences in the amino-terminal domain.
Lu ZH; Wang ZX; Horuk R; Hesselgesser J; Lou YC; Hadley TJ; Peiper SC
J Biol Chem; 1995 Nov; 270(44):26239-45. PubMed ID: 7592830
[TBL] [Abstract][Full Text] [Related]
17. The chemokine receptor D6 constitutively traffics to and from the cell surface to internalize and degrade chemokines.
Weber M; Blair E; Simpson CV; O'Hara M; Blackburn PE; Rot A; Graham GJ; Nibbs RJ
Mol Biol Cell; 2004 May; 15(5):2492-508. PubMed ID: 15004236
[TBL] [Abstract][Full Text] [Related]
18. Cutting edge: scavenging of inflammatory CC chemokines by the promiscuous putatively silent chemokine receptor D6.
Fra AM; Locati M; Otero K; Sironi M; Signorelli P; Massardi ML; Gobbi M; Vecchi A; Sozzani S; Mantovani A
J Immunol; 2003 Mar; 170(5):2279-82. PubMed ID: 12594248
[TBL] [Abstract][Full Text] [Related]
19. A high endothelial venule secretory protein, mac25/angiomodulin, interacts with multiple high endothelial venule-associated molecules including chemokines.
Nagakubo D; Murai T; Tanaka T; Usui T; Matsumoto M; Sekiguchi K; Miyasaka M
J Immunol; 2003 Jul; 171(2):553-61. PubMed ID: 12847218
[TBL] [Abstract][Full Text] [Related]
20. Chemokines on the move: control by the chemokine "interceptors" Duffy blood group antigen and D6.
Nibbs R; Graham G; Rot A
Semin Immunol; 2003 Oct; 15(5):287-94. PubMed ID: 15001178
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
